ORENCIA
NDC 0003-2814, abatacept, injection, solution, from E.R. Squibb & Sons, L.L.C..
- Product NDC
- 0003-2814
- Status
- Listed
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125118
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0003-2814 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ABATACEPT50 mg/.4mL
Pharmacologic classes
Decreased Cytokine Activity [PE]; Recombinant Fusion Proteins [CS]; Selective T Cell Costimulation Modulator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0003-2814-11 | 00003281411 | 4 SYRINGE, GLASS in 1 CARTON (0003-2814-11) / .4 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0836c6ac-ee37-5640-2fed-a3185a0b16ebMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0003-2814
Use it
Look up 0003-2814 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0003-2814 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0003-2814. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.